Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
JAMA Ophthalmology
|
April 15, 2016
Enhancing the Value of Preschool Vision Screenings
Eric L Ross, Joshua D Stein
Psychiatric Services (Washington, D.C.)
|
July 8, 2020
Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States
Eric L Ross, Djøra I Soeteman
JAMA Psychiatry
|
May 26, 2018
Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States
Eric L Ross, Kara Zivin, Daniel F Maixner
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 16, 2016
Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men
Eric L Ross, Sandro K Cinti, David W Hutton
JAMA Neurology
|
March 28, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Eric L Ross, Marc S Weinberg, Steven E Arnold
JAMA Neurology
|
October 3, 2022
Effectiveness-Essential for Cost-effectiveness-Reply
Eric L Ross, Marc S Weinberg, Steven E Arnold
Annals of Internal Medicine
|
October 29, 2019
The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model
Eric L Ross, Sandeep Vijan, Erin M Miller, et al.
The Journal of Clinical Psychiatry
|
November 19, 2020
Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States
Eric L Ross, Jessica E Becker, Jenny J Linnoila, et al.
JAMA Psychiatry
|
March 17, 2021
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US
Eric L Ross, Kelly L Zuromski, Ben Y Reis, et al.
JAMA Ophthalmology
|
June 10, 2016
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L Ross, David W Hutton, Joshua D Stein, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
JAMA Ophthalmology
|
April 15, 2016
Enhancing the Value of Preschool Vision Screenings
Eric L Ross, Joshua D Stein
Psychiatric Services (Washington, D.C.)
|
July 8, 2020
Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States
Eric L Ross, Djøra I Soeteman
JAMA Psychiatry
|
May 26, 2018
Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States
Eric L Ross, Kara Zivin, Daniel F Maixner
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 16, 2016
Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men
Eric L Ross, Sandro K Cinti, David W Hutton
JAMA Neurology
|
March 28, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Eric L Ross, Marc S Weinberg, Steven E Arnold
JAMA Neurology
|
October 3, 2022
Effectiveness-Essential for Cost-effectiveness-Reply
Eric L Ross, Marc S Weinberg, Steven E Arnold
Annals of Internal Medicine
|
October 29, 2019
The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model
Eric L Ross, Sandeep Vijan, Erin M Miller, et al.
The Journal of Clinical Psychiatry
|
November 19, 2020
Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States
Eric L Ross, Jessica E Becker, Jenny J Linnoila, et al.
JAMA Psychiatry
|
March 17, 2021
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US
Eric L Ross, Kelly L Zuromski, Ben Y Reis, et al.
JAMA Ophthalmology
|
June 10, 2016
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L Ross, David W Hutton, Joshua D Stein, et al.
Page
of 3